Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah D Stocken

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Diabetes Care|December 14, 2022
Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES TrialRamzi A Ajjan, Simon R Heller, Colin C Everett, et al.
The British Journal of Surgery|September 30, 2025
Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trialJack A Helliwell, Caroline H Chilton, Caroline Young, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Bone & Joint Open|August 5, 2025
Knee arthroplasty compared with joint distraction for osteoarthritis: a phase III randomized controlled trialThomas W Hamilton, Beth Lineham, Deborah D Stocken, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
Cancer Research|January 26, 2013
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patientsEdwin P Hui, Graham S Taylor, Hui Jia, et al.
Circulation|November 9, 2020
Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"John Gierula, Judith E Lowry, Maria F Paton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Clinical and genetic characteristics of hereditary pancreatitis in EuropeNathan Howes, Markus M Lerch, William Greenhalf, et al.
Circulation|April 18, 2020
Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II StudyJohn Gierula, Judith E Lowry, Maria F Paton, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Diabetes Care|December 14, 2022
Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES TrialRamzi A Ajjan, Simon R Heller, Colin C Everett, et al.
The British Journal of Surgery|September 30, 2025
Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trialJack A Helliwell, Caroline H Chilton, Caroline Young, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Bone & Joint Open|August 5, 2025
Knee arthroplasty compared with joint distraction for osteoarthritis: a phase III randomized controlled trialThomas W Hamilton, Beth Lineham, Deborah D Stocken, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
Cancer Research|January 26, 2013
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patientsEdwin P Hui, Graham S Taylor, Hui Jia, et al.
Circulation|November 9, 2020
Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"John Gierula, Judith E Lowry, Maria F Paton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Clinical and genetic characteristics of hereditary pancreatitis in EuropeNathan Howes, Markus M Lerch, William Greenhalf, et al.
Circulation|April 18, 2020
Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II StudyJohn Gierula, Judith E Lowry, Maria F Paton, et al.
Pageof 7